Additional file 3: Fig S1: exSTRa plots of EGA and simulated genomes. Fig S2: Decision tree model of the default analysis of Isaac-aligned EGA genomes on the training dataset. Fig S3: Performance metrics of the decision tree model in the default analysis of Isaac-aligned EGA genomes on the test dataset. Fig S4: Decision tree model of the default analysis of BWA-aligned EGA genomes on the training dataset. Fig S5: Performance metrics of the decision tree model in the default analysis of BWA-aligned EGA genomes on the test dataset. Fig S6: exSTRa plots of EGA genomes analyzed with 100 controls. Fig S7: Decision tree model of the modified analysis of Isaac-aligned EGA genomes on the training dataset. Fig S8: Performance metrics of decision tre...
Output from the CCLE genomic workflow (BEEM) and mapping to genes from the Hoffman epigenetic screen...
Table S1. Sequencing and mapping statistics. Listed are the sequencing details and mapping statistic...
Table S1. Clinical and biological data of the patients included in the study. Table S2. Tagmented DN...
Additional file 2: Table S3: CAUSES exome sequence data summary. Table S4: Commands and parameters u...
Additional file 1: Table S1: Experimental repeat size data of the samples in the Coriell European Ge...
Systematic approach to study exome capture variability in exome-sequencing (A) Three-generation pedi...
Background: Screening for short tandem repeat (STR) expansions in next-generation sequencing data ca...
Figure S3. Representation of the GWAS hits in the 5 non-accessory genes used in calculation of a ris...
Accuracy of GPGA in Human Chromosome 21 annotation; Table S7-S10; Figure S1 (a) and (b). Table S7. T...
PARADIGM analysis in The Cancer Genome Atlas (TCGA). Table S1. Pathways detected by gene set enrichm...
Figure S1. A) The proportion of recovered enhancer associated genes (EAG) as a function of random su...
Table S3. The calculated FST and FST difference data used for analyses. FST matrix of populations ba...
A scatter plot showing correlation of percent of homozygosity with the number of homozygous likely g...
Supplementary Tables S1-S5. Table S1. Datasets used. Information provided includes data type, provid...
Titration of percentage target exome sequenced as a function of depth of sequencing thresholds. (XLS...
Output from the CCLE genomic workflow (BEEM) and mapping to genes from the Hoffman epigenetic screen...
Table S1. Sequencing and mapping statistics. Listed are the sequencing details and mapping statistic...
Table S1. Clinical and biological data of the patients included in the study. Table S2. Tagmented DN...
Additional file 2: Table S3: CAUSES exome sequence data summary. Table S4: Commands and parameters u...
Additional file 1: Table S1: Experimental repeat size data of the samples in the Coriell European Ge...
Systematic approach to study exome capture variability in exome-sequencing (A) Three-generation pedi...
Background: Screening for short tandem repeat (STR) expansions in next-generation sequencing data ca...
Figure S3. Representation of the GWAS hits in the 5 non-accessory genes used in calculation of a ris...
Accuracy of GPGA in Human Chromosome 21 annotation; Table S7-S10; Figure S1 (a) and (b). Table S7. T...
PARADIGM analysis in The Cancer Genome Atlas (TCGA). Table S1. Pathways detected by gene set enrichm...
Figure S1. A) The proportion of recovered enhancer associated genes (EAG) as a function of random su...
Table S3. The calculated FST and FST difference data used for analyses. FST matrix of populations ba...
A scatter plot showing correlation of percent of homozygosity with the number of homozygous likely g...
Supplementary Tables S1-S5. Table S1. Datasets used. Information provided includes data type, provid...
Titration of percentage target exome sequenced as a function of depth of sequencing thresholds. (XLS...
Output from the CCLE genomic workflow (BEEM) and mapping to genes from the Hoffman epigenetic screen...
Table S1. Sequencing and mapping statistics. Listed are the sequencing details and mapping statistic...
Table S1. Clinical and biological data of the patients included in the study. Table S2. Tagmented DN...